Inventor · disambiguated record
Chijian Zuo
Also filed as: Zuo Chijian
3 granted patents·5 pending applications·1 citations·filing 2021–2025
49Inventor score
Files withPURECODON HONG KONG BIOPHARMA LTD5SUZHOU CUREMED BIOMEDICAL TECH CO LTD2JIANGSU PURECELL BIOMEDICAL TECH CO LTD1
Top patents by PatentIndex Score
8 records- 0184US11634727B2Recombinant nucleic acid molecule of transcriptional circular RNA and its application in protein expressionPURECODON HONG KONG BIOPHARMA LTD·Filed 2021·Granted Apr 25, 2023·1 cites·8 claims
- 0262US12331290B2Recombinant nucleic acid molecule and application thereof in preparation of circular RNAPURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Granted Jun 17, 2025·0 cites·14 claims
- 0361US2025270544A1Recombinant nucleic acid molecule and application thereof in preparation of circular rnaPURECODON HONG KONG BIOPHARMA LTD·Filed 2025·Application pending·0 cites
- 0458US2022177908A1Recombinant nucleic acid molecule of transcriptional circular rna and its application in protein expressionJIANGSU PURECELL BIOMEDICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0554US12054722B2Recombinant nucleic acid molecule based on point mutation of translation initiation element and use thereof in preparation of circular RNAPURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Granted Aug 6, 2024·0 cites·14 claims
- 0654US2023119715A1Levenshtein distance-based ires screening method and polynucleotide screened based on samePURECODON HONG KONG BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 0754US2023060661A1Tissue-specifically expressed circular rna molecule and application thereofSUZHOU CUREMED BIOMEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0853US2023042694A1Circular rna molecule and use thereof in targeted degradation of protein of interestSUZHOU CUREMED BIOMEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chijian Zuo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →